MindWalk Holdings (HYFT) Profit After Tax Growth (1y) (2021 - 2026)
MindWalk Holdings (HYFT) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
66.06% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
17.05% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-290.15% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
-129.68% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
-632.44% |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
MindWalk Holdings |
166.20 Mn |
156.06 Mn |
1.78 |
99.90% |
| Date | Value |
| Jan 31, 2026 |
99.90% |
| Oct 31, 2025 |
26.48% |
| Jul 31, 2025 |
-100.10% |
| Apr 30, 2025 |
-41,160.16% |
| Jan 31, 2025 |
-587.70% |
| Oct 31, 2024 |
-62.01% |
| Jul 31, 2024 |
14.11% |
| Apr 30, 2024 |
-691.09% |
| Jan 31, 2024 |
24.94% |
| Oct 31, 2023 |
65.65% |
| Jul 31, 2023 |
135.09% |
| Apr 30, 2023 |
4.61% |
| Jan 31, 2023 |
-12.73% |
| Oct 31, 2022 |
-141,187.84% |
| Jul 31, 2022 |
-277,296.20% |
| Apr 30, 2022 |
-49.89% |
| Jan 31, 2022 |
-200.37% |
| Oct 31, 2021 |
99.61% |
| Apr 30, 2021 |
-285.38% |